RCE 3.36% 57.5¢ recce pharmaceuticals ltd

Ann: Cohort Dosing Complete Ph I/II UTI/Urosepsis Clinical Trial, page-5

  1. 562 Posts.
    lightbulb Created with Sketch. 335
    Oh, Recce. You never fail to disappoint. I count three bald-faced lies in just the first two lines of this announcement!
    The Donald Trump of the ASX.

    Lie 1: RCE call it a "Phase I/II" but it is just a phase 1.

    Lie 2: RCE say they have dosed "clinical subjects" but they are dosing healthy subjects.

    Lie 3: They say it's a "UTI/Urosepsis" clinical trial but it's a safety / pharmacokinetics trial.

    Source: Their own trial data
    https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385744
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
57.5¢
Change
-0.020(3.36%)
Mkt cap ! $117.2M
Open High Low Value Volume
57.5¢ 58.0¢ 57.5¢ $13.44K 23.37K

Buyers (Bids)

No. Vol. Price($)
1 143 57.5¢
 

Sellers (Offers)

Price($) Vol. No.
58.0¢ 4749 2
View Market Depth
Last trade - 15.57pm 21/06/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.